HARBIN, China, Nov. 4 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that it will conduct a conference call at 9:00 A.M. Eastern Time on November 10, 2008 to discuss its third quarter 2008 financial results.
Joining Mr. Yan-qing Liu, Chairman, CEO and Director of China Sky One Medical, Inc., will be Yu-bo Hao, Board Secretary. The Company plans to issue an earnings announcement prior to the call.
To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: (866) 573-1052. International callers should dial (702) 696-4500. The Conference ID for this call is 72520119.
If you are unable to participate in the call at this time, a replay will be available for fourteen days starting on Monday, November 10, 2008 at 12 P.M. Eastern Time. To access the replay, dial (800) 642-1687, international callers dial (706) 645-9291 Conference ID 72520119
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR") and Harbin First Bio- Engineering Company Limited ("First"), the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.skyonemedical.com .
Safe Harbor Statement
Certain of the statements made in the press release constitute forward-
looking statements within the meaning of the Private Securities Litigation
Reform Act of 1995. These statements can be identified by the use of
forward- looking terminology such as "believe," "expect," "may," "will,"
"should," "project," "plan," "seek," "intend," or "anticipate" or the
negative thereof or comparable terminology. Such statements typically
involve risks and uncertainties and may include financial projections or
information regarding our future plans, objectives or performance. Actual
results could differ materially from the expectations reflected in such
forward-looking statements as a result of a variety of factors, including
the risks associated with the effect of changing economic conditions in The
People's Republic of China, variations in cash flow, reliance on
collaborative retail partners and on new product development, variations in
new product development, risks associated with rapid technological change,
and the potential of introduced or undetected flaws and defects in
products, and other risk factors detailed in reports filed with the
Securities and Exchange Commission from time to time.
For more information, please contact:
China Sky One Medical, Inc.
Mr. Yu-bo Hao, Board Secretary
Investor Relations Contact:
CCG Investor Relations
Mr. Crocker Coulson, President
Mr. Richard Micchelli, Financial Writer
Web site: http://www.ccgirasia.com
|SOURCE China Sky One Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved